Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Equity (Unaudited)

v3.22.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings/ (Loss)
Accumulated Other Comprehensive Income/(Loss)
Employees
Common Stock
Executive Officer
Common Stock
Director
Common Stock
Beginning balance (in shares) at Mar. 31, 2021   33,225,808            
Beginning balance at Mar. 31, 2021 $ 378,872 $ 33 $ 231,322 $ 183,436 $ (35,919)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in exercise of stock options (in shares)   8,100            
Issuance of common stock in exercise of stock options 97 $ 0 97          
Issuance of common stock (in shares)           23,858 42,326 7,368
Stock compensation expense 1,178   1,178          
Repurchase of employee stock units on vesting (548)   (548)          
Net income/(loss) (340)     (340)        
Foreign currency translation adjustment 4,302       4,302      
Other (64)       (64)      
Ending balance (in shares) at Jun. 30, 2021   33,307,460            
Ending balance at Jun. 30, 2021 $ 383,497 $ 33 232,049 183,096 (31,681)      
Beginning balance (in shares) at Mar. 31, 2022 33,364,722 33,364,722            
Beginning balance at Mar. 31, 2022 $ 399,204 $ 33 234,549 203,528 (38,906)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock (in shares)           30,352 64,294 8,766
Stock compensation expense 1,193   1,193          
Repurchase of employee stock units on vesting (552)   (552)          
Net income/(loss) 6,556     6,556        
Foreign currency translation adjustment (5,152)     0 (5,152)      
Other $ 3     1 2      
Ending balance (in shares) at Jun. 30, 2022 33,468,134 33,468,134            
Ending balance at Jun. 30, 2022 $ 401,252 $ 33 $ 235,190 $ 210,085 $ (44,056)